NGVTIngevity Corporation
Ingevity Corporation (NGVT) is a specialty chemicals company that produces and sells industrial gases, catalysts, and specialty chemicals used in a range of applications, including manufacturing, energy, and healthcare. The next catalyst is Nov 3, 2026 — Q3 2026 Earnings Release, which will test the company’s ability to sustain margin expansion and meet its 2026 guidance. The event will also provide clarity on the impact of pricing power and volume growth, which were key drivers in the recent 4% rally in August 2026 .
- Revenue growth slowed to -2.7% YoY in 2025, but free cash flow remained robust at $238.6M TTM.
- Net margin hit 16.0% TTM, up from prior periods, driven by favorable pricing and product mix.
- Debt / equity stands at 40.69x, reflecting a leveraged capital structure that could be tested by new debt refinancing in late 2026.
The schedule
- Thu5Nov
The earnings release will test whether Ingevity can sustain margin expansion and guide for Q4, following a recent revenue miss in Q2. The focus will be on the guidance reset and the mix of services versus product revenue.
- Tue8Dec
The event will test the company's ability to secure favorable terms for debt refinancing and showcase its strategic direction, particularly in the energy transition. The focus will be on the clarity of the roadmap and the potential for capital structure optimization.
- Tue9Feb
This report will test the ability to deliver on the guidance from Q3 and show progress in the energy transition. The focus will be on the cash flow generation and the mix of services versus product revenue.
- Sat15May
The earnings release will test whether Ingevity can sustain margin expansion and guide for Q2, following a recent revenue miss in Q2. The focus will be on the guidance reset and the mix of services versus product revenue.
- Fri30Jul
This event will test the company's ability to maintain investor confidence and provide a clear roadmap for future growth, particularly in the energy transition. The focus will be on the timing and content of the upcoming investor day.
- Tue3Aug
This report will test the ability to deliver on the guidance from Q1 and show progress in the energy transition. The focus will be on the cash flow generation and the mix of services versus product revenue.
- Fri10Sep
The webcast will test the company's ability to communicate its strategic priorities and financial outlook, particularly in the context of the energy transition. The focus will be on the clarity of messaging and the alignment with investor expectations.
- Thu23Sep
The speech will test the company's ability to reinforce its strategic priorities and financial outlook, particularly in the energy transition. The focus will be on the clarity of messaging and the alignment with investor expectations.
- Thu4Nov
Past
- Sat26Sep
Actual outcome: Bear · $69.91 at outcome
Ingevity (NGVT) stock fell 4.4% from the event date to the outcome date, reflecting investor caution following a mixed earnings report. While revenue exceeded expectations, the EPS miss and weak guidance on near-term growth concerns pressured the stock. The decline suggests the market discounted the recent gains and focused on the lack of clear catalysts to sustain momentum.
Ingevity (NGVT) Stock Looks Stretched On Its 52% Three Year Run
- Tue15Sep
Actual outcome: Mixed · $68.93 at outcome
The stock closed at $68.93 on the outcome date, showing a 1.7% rise from the event date. However, the price subsequently climbed to $73.10, surpassing the bull target. This movement was driven by positive developments in the EPA emissions policy update, which signaled potential regulatory changes that could benefit Ingevity's business, reinforcing the bull case.
A potential review or rollback of EPA tailpipe emission standards under the Trump Administration poses a material threat to Ingevity's activated carbon sales, driving a $73.00 target or $62.00 fallback.
- Tue4Aug
Actual outcome: Bull · $77.04 at outcome
Ingevity delivered strong Q2 results, driven by favorable pricing, product mix, and higher volumes that successfully expanded margins. The company also raised its full-year adjusted EBITDA and earnings-per-share outlook, reassuring the market about margin sustainability and driving the stock higher toward the bull target.
The market will scrutinize Q2 results to see if the recent margin recovery is sustainable amidst mixed global auto demand and a $1.2B debt load, with a target of $78.50 and a fallback of $69.00.
- Wed25Feb
Actual outcome: Bull · $70.52 at outcome
Ingevity reported full-year and fourth-quarter 2025 results, beating revenue expectations and providing optimistic 2026 guidance. The company highlighted strong demand trends, cost management, and capital investments, which reinforced investor confidence. The stock rallied as the positive outlook and strategic focus aligned with the bull target, moving above $66.50 despite a slight EPS miss.